Search results
Results from the WOW.Com Content Network
Jarvik 2000: Jarvik Heart: Continuous flow, axial rotor supported by ceramic bearings. Currently used in the United States as a bridge to heart transplant under an FDA-approved clinical investigation. In Europe, the Jarvik 2000 has earned CE Mark certification for both bridge-to-transplant and lifetime use. Child version currently being developed.
Peter Houghton (20 August 1938 – 25 November 2007) was the longest surviving artificial heart transplant patient in the UK. [1] [2]Houghton was implanted with a Jarvik 2000 heart pump at the John Radcliffe Hospital, Oxford, England, by professor Stephen Westaby, on 20 June 2000 owing to severe heart failure.
Robert Jarvik was born in Midland, Michigan, to Norman Eugene Jarvik and Edythe Koffler Jarvik, and raised in Stamford, Connecticut. [1] He is brother to Jonathan Jarvik, a biological-sciences professor at Carnegie Mellon University, [2] as well as the nephew of Murray Jarvik, a pharmacologist who co-invented the nicotine patch.
His most significant contribution was the development of the nonpulsatile implantable LVADs, the Jarvik, HeartMate II and HeartWare. [6] After more than ten years of research, in 2000, he performed the first implant of the Jarvik 2000 LVAD into a human, also a continuous flow pump. [1]
Since 1982, 350 patients have used the Jarvik-7 heart model, and its original design is still used for the modern Jarvik-7, although due to propriety passages the device name is now "SynCardia". In October 2004, the Jarvik-7 model was the first medical device to receive a full-FDA approval. [11]
Jack Greene Copeland (born 1942) is an American cardiothoracic surgeon, who has established procedures in heart transplantation including repeat heart transplantation, the implantation of total artificial hearts (TAH) to bridge the time to heart transplant, innovations in left ventricular assist devices (LVAD) and the technique of "piggybacking" a second heart (heterotopic heart transplant) in ...
Westaby and his team performed Peter Houghton's heart operation in June 2000, implanting a Jarvik 7 artificial left ventricular assist device, a turbine pump. Peter Houghton (1938–2007) became the longest living person with an electrical heart pump in the world.
In 2000, Texas Heart Institute became the first site for clinical trials of the Jarvik 2000. [24] The next year, Texas Heart Institute became the first to demonstrate that C-Reactive Protein (CRP) causes vascular inflammation. [25] That same year, Texas Heart Institute performed its 100,000th open heart operation. [26]